CinDome Pharma Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$40M
- Investors
-
2
CinDome Pharma General Information
Description
Operator of a biopharmaceutical therapy platform designed to develop long-term treatments for gastrointestinal disorders and chronic digestive conditions. The company offers drug development capabilities focused on engineered gastrointestinal therapies with clinical research, safety-focused formulation design, and dopamine receptor targeting technology, enabling healthcare providers and patients with digestive disorders to access chronic treatment options with improved tolerability and symptom management.
Contact Information
Website
www.cindome.comCorporate Office
- 5375 Medpace Way
- Cincinnati, OH 45227
- United States
Corporate Office
- 5375 Medpace Way
- Cincinnati, OH 45227
- United States
CinDome Pharma Timeline
CinDome Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 04-Jun-2025 | $40M | Completed | Clinical Trials - Phase 2 | ||
| 1. Later Stage VC (Series B) | 16-May-2024 | Completed | Clinical Trials - Phase 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CinDome Pharma Comparisons
Industry
Financing
Details
CinDome Pharma Competitors (2)
One of CinDome Pharma’s 2 competitors is Aclipse Therapeutics, a Venture Capital-Backed company based in King of Prussia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aclipse Therapeutics | Venture Capital-Backed | King of Prussia, PA | ||||
| Evoke Pharma | Formerly VC-backed | Solana Beach, CA |
CinDome Pharma Patents
CinDome Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025226772-A1 | Methods for treating gastroesophagael symptoms in cystic fibrosis patients | Pending | 23-Apr-2024 | ||
| AU-2024238849-A1 | Methods for treating diabetic gastroparesis | Pending | 23-Mar-2023 | ||
| EP-4683633-A1 | Methods for treating diabetic gastroparesis | Pending | 23-Mar-2023 | ||
| WO-2024197230-A1 | Methods for treating diabetic gastroparesis | Inactive | 23-Mar-2023 | ||
| AU-2023256584-A1 | Deuterated domperidone for treating gastroparesis | Pending | 20-Apr-2022 | A61K31/454 |
CinDome Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CinRx Pharma | VC-Backed Company | Minority | ||
| Perceptive Advisors | Venture Capital | Minority |
CinDome Pharma FAQs
-
When was CinDome Pharma founded?
CinDome Pharma was founded in 2019.
-
Where is CinDome Pharma headquartered?
CinDome Pharma is headquartered in Cincinnati, OH.
-
What industry is CinDome Pharma in?
CinDome Pharma’s primary industry is Drug Discovery.
-
Is CinDome Pharma a private or public company?
CinDome Pharma is a Private company.
-
What is CinDome Pharma’s current revenue?
The current revenue for CinDome Pharma is .
-
How much funding has CinDome Pharma raised over time?
CinDome Pharma has raised $99M.
-
Who are CinDome Pharma’s investors?
CinRx Pharma and Perceptive Advisors have invested in CinDome Pharma.
-
Who are CinDome Pharma’s competitors?
Aclipse Therapeutics and Evoke Pharma are competitors of CinDome Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process